Home Featured

Featured

Michael Ryoshin Sapiro, PsyD – Truth Medicine, Psychedelics, and Living Your Truth

What the Cancer Community Actually Needs from Psychedelic Care

Bringing Psilocybin to Market: Compass’ Steve Levine on Infrastructure, Access and Competition

Joe Moore & Kyle Buller: Breathwork, Somatics, and Foundations for Psychedelic Work

Navigators Film Club – Last Journey

Alexander Beiner – Psychedelics, Culture, and the Games We Play

Kyle Buller – How to Stay Grounded in Chaos: Breathwork, Psychedelics...

The Psychedelic News Feed: November 17 – 23, 2025

ARPA-H Launches $100M Effort to “Demystify” Mental Health and Catalyse Rapid-Acting...

Evelyn Eddy Shoop MSN, APRN, PMHNP-BC: Lived Experience, Qualitative Data, and...

Pα+ Psychedelic Bulletin #214: LSD Microdosing Program Collapses; AtaiBeckley’s Phase 2b...

Dr Jason Konner – Psychedelic Oncology and the Future of Cancer...

The Psychedelic News Feed: November 3 – 9, 2025

The Psychedelic News Feed: November 10 – 16, 2025

Beyond the Brain Reset: Óscar Soto on Mechanisms of Psychedelic Action

12 3...303 Page 1 of 303

Michael Ryoshin Sapiro, PsyD – Truth Medicine, Psychedelics, and Living Your...

What the Cancer Community Actually Needs from Psychedelic Care

Bringing Psilocybin to Market: Compass’ Steve Levine on Infrastructure, Access and...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Michael Ryoshin Sapiro, PsyD – Truth Medicine, Psychedelics, and Living Your Truth

What the Cancer Community Actually Needs from Psychedelic Care

Bringing Psilocybin to Market: Compass’ Steve Levine on Infrastructure, Access and Competition

Joe Moore & Kyle Buller: Breathwork, Somatics, and Foundations for Psychedelic Work

Navigators Film Club – Last Journey

Alexander Beiner – Psychedelics, Culture, and the Games We Play

Kyle Buller – How to Stay Grounded in Chaos: Breathwork, Psychedelics...

The Psychedelic News Feed: November 17 – 23, 2025

ARPA-H Launches $100M Effort to “Demystify” Mental Health and Catalyse Rapid-Acting...

Evelyn Eddy Shoop MSN, APRN, PMHNP-BC: Lived Experience, Qualitative Data, and...

Pα+ Psychedelic Bulletin #214: LSD Microdosing Program Collapses; AtaiBeckley’s Phase 2b...

Dr Jason Konner – Psychedelic Oncology and the Future of Cancer...

The Psychedelic News Feed: November 3 – 9, 2025

The Psychedelic News Feed: November 10 – 16, 2025

Beyond the Brain Reset: Óscar Soto on Mechanisms of Psychedelic Action

EDITOR PICKS

Michael Ryoshin Sapiro, PsyD – Truth Medicine, Psychedelics, and Living Your...

What the Cancer Community Actually Needs from Psychedelic Care

Bringing Psilocybin to Market: Compass’ Steve Levine on Infrastructure, Access and...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY